Fineotex Chemical Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fineotex Chemical reported consolidated total income of Rs. 19,046 lakhs for Q3 FY26, up 30.96% quarter-on-quarter and 45.49% year-on-year. Profit after tax rose 15.50% Q-o-Q to Rs. 3,012 lakhs but only 8.23% YoY, while operational EBITDA grew 12.28% Q-o-Q to Rs. 3,484 lakhs, indicating margin compression as revenue outpaced profit growth. Consolidated volume grew approximately 39% YoY, and ROIC stood at 26.82%. During the quarter, the company completed the acquisition of US-based specialty chemical group CrudeChem Technologies (CCT Group) through a step-down subsidiary, marking entry into oilfield chemicals. Promoters exercised 5 lakh warrants, with Rs. 35.68 crores received from 75% warrant conversion. The statutory auditor (ASL & Co.) issued an unqualified limited review report.
Strong top-line growth driven by acquisition and volume expansion is positive for shareholders, but the gap between revenue growth (~46% YoY) and profit growth (~8% YoY) suggests margin pressure that could weigh on near-term stock sentiment. The US acquisition and promoter warrant conversion signal strategic expansion and insider confidence.